Nu Skin Enterprises (NUS)
(Delayed Data from NYSE)
$6.45 USD
+0.05 (0.78%)
Updated Oct 8, 2024 04:00 PM ET
After-Market: $6.44 -0.01 (-0.16%) 7:58 PM ET
5-Strong Sell of 5 5
A Value B Growth A Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$6.45 USD
+0.05 (0.78%)
Updated Oct 8, 2024 04:00 PM ET
After-Market: $6.44 -0.01 (-0.16%) 7:58 PM ET
5-Strong Sell of 5 5
A Value B Growth A Momentum A VGM
Zacks News
Should Value Investors Buy Nu Skin Enterprises (NUS) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
NUS or EL: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
NUS vs. EL: Which Stock Is the Better Value Option?
Is Nu Skin Enterprises (NUS) Outperforming Other Consumer Staples Stocks This Year?
by Zacks Equity Research
Is (NUS) Outperforming Other Consumer Staples Stocks This Year?
New Strong Buy Stocks For November 16th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today:
Inter Parfums (IPAR) Q3 Earnings Beat Estimates, Sales Down
by Zacks Equity Research
Inter Parfums' (IPAR) third-quarter 2020 sales and earnings fall year over year. Nevertheless, results reflect sequential growth as stores reopened and e-commerce business was robust.
International Flavors (IFF) Q3 Earnings & Sales Lag Estimates
by Zacks Equity Research
International Flavors' (IFF) Fine Fragrance and Food Service categories witness declines due to the COVID-19 pandemic during the July-September quarter.
Coty (COTY) Up More Than 20% on Q1 Earnings & Sales Beat
by Zacks Equity Research
Coty's (COTY) first-quarter fiscal 2021 results reflect e-commerce strength and gains from innovation. Also, solid cost savings are a driver.
Nu Skin (NUS) Tops Q3 Earnings Estimates, Raises 2020 View
by Zacks Equity Research
Strong growth in sales leaders and customer base, as well as robust digital growth drive Nu Skin's (NUS) performance for third-quarter 2020.
Nu Skin Enterprises (NUS) Q3 Earnings Surpass Estimates
by Zacks Equity Research
Nu Skin (NUS) delivered earnings and revenue surprises of 9.09% and -0.06%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Factors Likely to Influence TreeHouse Foods' (THS) Q3 Earnings
by Zacks Equity Research
TreeHouse Foods' (THS) third-quarter 2020 results are likely to gain from increased demand and greater at-home consumption. However, high costs and a soft Food Away From Home business are concerning.
Here's How Flowers Foods (FLO) Looks Ahead of Q3 Earnings
by Zacks Equity Research
Strength in branded retail with Nature's Own, Canyon Bakehouse, Dave's Killer Bread and Wonder brands is likely to get reflected in Flowers Foods' (FLO) third-quarter performance.
How Prestige Consumer (PBH) Looks Just Ahead of Q2 Earnings
by Zacks Equity Research
Prestige Consumer's (PBH) second-quarter fiscal 2021 performance is likely to reflect soft consumption in certain categories. Nevertheless, robust cost curtailment efforts bode well.
Is Nu Skin Enterprises (NUS) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Is Monster Beverage (MNST) Poised for an Earnings Beat in Q3?
by Zacks Equity Research
Monster Beverage (MNST) is likely to have gained from solid energy drinks business, improved at-home consumption trends and online demand in Q3. Cost leverage is likely to have aided earnings.
NUS vs. EL: Which Stock Is the Better Value Option?
by Zacks Equity Research
NUS vs. EL: Which Stock Is the Better Value Option?
Is Nu Skin Enterprises (NUS) Outperforming Other Consumer Staples Stocks This Year?
by Zacks Equity Research
Is (NUS) Outperforming Other Consumer Staples Stocks This Year?
Clorox's (CLX) Q1 Earnings & Sales Surpass Estimates, Up Y/Y
by Zacks Equity Research
Clorox's (CLX) first-quarter fiscal 2021 results reflect gains from robust demand for disinfecting and cleaning products due to the coronavirus outbreak and broad-based growth at all segments.
Estee Lauder (EL) Beats Q1 Earnings Estimates, Hikes Dividend
by Zacks Equity Research
Estee Lauder's (EL) first-quarter fiscal 2021 sales and earnings fall year over year. Results reflect adverse impact of some retail store closures and lower traffic in reopened stores amid COVID-19.
Nu Skin (NUS) to Report Q3 Earnings: What's in the Cards?
by Zacks Equity Research
Continued investment in digital capabilities and benefits from robust product portfolio are likely to get reflected in Nu Skin's (NUS) third-quarter 2020 performance.
Colgate (CL) Up on Q3 Earnings & Sales Beat, Gives Solid view
by Zacks Equity Research
Colgate (CL) reports accelerated earnings and sales growth in third-quarter 2020 on strong demand for its products, innovation and positive e-commerce trends.
Things You Should Know About Clorox (CLX) Ahead of Q1 Earnings
by Zacks Equity Research
Clorox's (CLX) Q1 top line is likely to have gained from continued strong product demand and growth across segments. Higher costs and investments to meet demand are likely to have hurt margins.
The Zacks Analyst Blog Highlights: Camping World, Nu Skin, Advanced Energy Industries, Advanced Drainage Systems and PennyMac Financial Services
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Camping World, Nu Skin, Advanced Energy Industries, Advanced Drainage Systems and PennyMac Financial Services
Altria's (MO) Q3 Earnings Surpass Estimates on Solid Pricing
by Zacks Equity Research
Altria's (MO) third-quarter 2020 results reflect strong pricing in smokeable and oral tobacco product segments. Management lifts the lower end of its previously guided earnings view.
Sysco (SYY) to Report Q1 Earnings: What Awaits the Stock?
by Zacks Equity Research
Sysco's (SYY) first-quarter fiscal 2021 performance is likely to reflect soft volumes in the away-from-home food channel due to the ongoing pandemic.
Service Corporation (SCI) Raises '20 View on Q3 Earnings Beat
by Zacks Equity Research
Service Corporation's (SCI) third-quarter 2020 results reflect higher earnings and sales, thanks to higher funeral services performed amid the pandemic. Management raises earnings guidance.